Jun 2026 (Q2 FY26) — Jul 30, 2026
Ryerson Q2 FY26 — Merger Synergies Drive Above-Guidance Performance Amidst Mixed Market
Read the full callRyerson (RYZ) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Ryerson earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 2,006 | +71.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 1.7 | +1.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 15.5 | +715.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$27.89 +1.57% · +$0.43
Performance +22.6% 1Y
1Y: $22.75 on 17 Oct 2025 → $27.89. High $31.03 (28 Jul 2026), low $19.86 (17 Nov 2025).
- Previous close
- $27.46
- 52-week range
- $19.86 – $31.03
- One year
- +21.21%
Overview
- Symbol
- RYZ
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Ryerson earnings calls (RYZ)
Financials
What the filings say
Net profit, year on year: +716% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,127 | 1,007 | 1,136 | 1,169 | 1,162 | 1,105 | 1,567 | 2,006 |
| Operating profit | 5 | 3 | 2 | 6 | -1 | -38 | 23 | 34 |
| Operating margin | 0.5% | 0.3% | 0.2% | 0.5% | −0.1% | −3.4% | 1.5% | 1.7% |
| Other income | -0 | 3 | 0 | -2 | 1 | -0 | 2 | 2 |
| Profit before tax | -6 | -5 | -7 | -6 | -10 | -48 | 13 | 22 |
| Tax rate | 6.3% | 12.5% | 23.2% | 133.3% | −39.8% | 21.4% | 62.1% | 27.3% |
| Net profit | -7 | -4 | -6 | 2 | -15 | -38 | 5 | 16 |
| EPS ($ per share) | -0.20 | — | -0.18 | 0.06 | -0.46 | — | 0.11 | 0.30 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | 14 | 100 | 34 | 322 | 693 | 813 | 780 | 699 |
| Total liabilities | 2,010 | 1,843 | 1,657 | 1,821 | 1,441 | 1,655 | 1,615 | 1,641 |
| Fixed assets | 489 | 440 | 422 | 388 | 458 | 590 | 637 | 610 |
| Total assets | 2,086 | 2,022 | 1,802 | 2,366 | 2,334 | 2,570 | 2,440 | 2,405 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 57 | 193 | 278 | 35 | 501 | 365 | 205 | 87 |
| Cash from investing | -200 | 26 | -26 | 94 | -160 | -262 | -143 | -54 |
| Cash from financing | 93 | -184 | -250 | -138 | -350 | -88 | -87 | -36 |
| Net cash flow | -54 | 36 | 3 | -10 | -12 | 15 | -26 | -1 |
| Capital expenditure | -38 | -46 | -26 | -59 | -105 | -122 | -100 | -51 |
| Free cash flow | 19 | 147 | 252 | -24 | 396 | 243 | 105 | 36 |
Insider filings
56 filings between Jan 1, 2026 and Jul 28, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$2.46M
8 sales by 4 insiders
75% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 26
- Award — granted as compensation
- 18
- Option exercise — converted options into shares
- 4
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Lehner Edward J. | — | $1.80M | Jan 22, 2026 |
| Silver Mark S. | — | $311.8K | May 28, 2026 |
| Kannan Molly D | — | $196.7K | Jul 28, 2026 |
| Claussen James J | — | $149.2K | Feb 3, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 28, 2026 | Kannan Molly D CAO & Corporate Controller | Sale 10b5-1 plan | 500 | $16.0K |
| Jul 23, 2026 | Leggio Karen Marie Director | Award | 97 | $0 |
| Jul 23, 2026 | Kumbier Michelle Director | Award | 97 | $0 |
| Jul 23, 2026 | Crawford Bruce T Director | Award | 97 | $0 |
| Jul 23, 2026 | Stovsky Richard P Director | Award | 97 | $0 |
| Jul 23, 2026 | CALHOUN KIRK K Director | Award | 97 | $0 |
| Jul 23, 2026 | CARRUTHERS COURT D Director | Award | 97 | $0 |
| Jul 23, 2026 | Scott Peter Jennings Director | Award | 97 | $0 |
| Jun 11, 2026 | Kannan Molly D CAO & Corporate Controller | Sale 10b5-1 plan | 1,000 | $30.0K |
| May 29, 2026 | Kannan Molly D CAO & Corporate Controller | Sale 10b5-1 plan | 3,000 | $85.3K |
| May 28, 2026 | Silver Mark S. EVP, Chief Legal/Risk Officer | Sale | 11,174 | $311.8K |
| May 13, 2026 | Kannan Molly D CAO & Corporate Controller | Sale | 2,500 | $65.5K |
| Apr 10, 2026 | Scott Peter Jennings Director | Award | 203 | $0 |
| Apr 10, 2026 | CARRUTHERS COURT D Director | Award | 389 | $0 |
| Apr 10, 2026 | Kumbier Michelle Director | Award | 389 | $0 |
| Apr 10, 2026 | Crawford Bruce T Director | Award | 389 | $0 |
| Apr 10, 2026 | Leggio Karen Marie Director | Award | 389 | $0 |
| Apr 10, 2026 | Larson Stephen P. Director | Award | 462 | $0 |
| Apr 10, 2026 | CALHOUN KIRK K Director | Award | 389 | $0 |
| Apr 10, 2026 | Stovsky Richard P Director | Award | 203 | $0 |
| Mar 31, 2026 | Kannan Molly D CAO & Corporate Controller | Tax withheld | 4,691 | $105.5K |
| Mar 31, 2026 | Kannan Molly D CAO & Corporate Controller | Option exercise | 5,863 | $0 |
| Mar 31, 2026 | Kannan Molly D CAO & Corporate Controller | Option exercise | 2,275 | $0 |
| Mar 31, 2026 | Kannan Molly D CAO & Corporate Controller | Option exercise | 2,063 | $0 |
| Mar 31, 2026 | Kannan Molly D CAO & Corporate Controller | Option exercise | 2,110 | $0 |
| Mar 31, 2026 | Claussen James J Executive Vice President & CFO | Option exercise | 11,725 | $0 |
| Mar 31, 2026 | Claussen James J Executive Vice President & CFO | Tax withheld | 10,415 | $234.1K |
| Mar 31, 2026 | Claussen James J Executive Vice President & CFO | Option exercise | 4,125 | $0 |
| Mar 31, 2026 | Silver Mark S. EVP, Chief Legal/Risk Officer | Tax withheld | 7,509 | $168.8K |
| Mar 31, 2026 | Lehner Edward J. CEO | Option exercise | 13,258 | $0 |
| Mar 31, 2026 | Claussen James J Executive Vice President & CFO | Option exercise | 4,219 | $0 |
| Mar 31, 2026 | Claussen James J Executive Vice President & CFO | Option exercise | 4,550 | $0 |
| Mar 31, 2026 | Silver Mark S. EVP, Chief Legal/Risk Officer | Option exercise | 3,412 | $0 |
| Mar 31, 2026 | Silver Mark S. EVP, Chief Legal/Risk Officer | Option exercise | 2,947 | $0 |
| Mar 31, 2026 | Silver Mark S. EVP, Chief Legal/Risk Officer | Option exercise | 3,014 | $0 |
| Mar 31, 2026 | Lehner Edward J. CEO | Tax withheld | 32,000 | $719.4K |
| Mar 31, 2026 | Lehner Edward J. CEO | Option exercise | 36,850 | $0 |
| Mar 31, 2026 | Silver Mark S. EVP, Chief Legal/Risk Officer | Option exercise | 8,375 | $0 |
| Mar 31, 2026 | Lehner Edward J. CEO | Option exercise | 12,513 | $0 |
| Mar 31, 2026 | Lehner Edward J. CEO | Option exercise | 12,965 | $0 |
| Feb 26, 2026 | Lehner Edward J. CEO | Option exercise | 3,750 | $61.9K |
| Feb 26, 2026 | Lehner Edward J. CEO | Option exercise | 5,000 | $82.5K |
| Feb 13, 2026 | Greiff Andrew S EVP | Award | 33,975 | — |
| Feb 13, 2026 | Scott Peter Jennings Director | Award | 8,603 | — |
| Feb 13, 2026 | Stovsky Richard P Director | Award | 17,499 | — |
| Feb 13, 2026 | SIEGAL MICHAEL D Director | Award | 1,825,226 | — |
| Feb 13, 2026 | MARABITO RICHARD T President & COO | Award | 125,292 | — |
| Feb 3, 2026 | Claussen James J Executive Vice President & CFO | Sale 10b5-1 plan | 4,972 | $149.2K |
| Jan 22, 2026 | Lehner Edward J. President & CEO | Sale 10b5-1 plan | 59,001 | $1.77M |
| Jan 21, 2026 | Lehner Edward J. President & CEO | Sale 10b5-1 plan | 1,000 | $30.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Ryerson Holding Corp
Free account. Everything above stays public.
Write why you follow Ryerson Holding Corp and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading